CRISPR THERAPEUTICS AG Increase (Decrease) in Other Operating Liabilities
CRISPR THERAPEUTICS AG (CRSP) reported Increase (Decrease) in Other Operating Liabilities of $3.95 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2026-08-03
- CRISPR THERAPEUTICS AG increase (decrease) in other operating liabilities for the quarter ending 2026-06-30 was $4.15M, a 836.12% increase year-over-year.
- CRISPR THERAPEUTICS AG increase (decrease) in other operating liabilities for the quarter ending 2026-03-31 was -$199.00K.
- CRISPR THERAPEUTICS AG increase (decrease) in other operating liabilities for the quarter ending 2025-12-31 was $13.55M, a 35.74% increase year-over-year.
- CRISPR THERAPEUTICS AG increase (decrease) in other operating liabilities for the quarter ending 2025-09-30 was $802.00K, a 2487.10% increase year-over-year.
- CRISPR THERAPEUTICS AG increase (decrease) in other operating liabilities for fiscal 2025 was $4.26M, a 55.76% decline from fiscal 2024.
- CRISPR THERAPEUTICS AG increase (decrease) in other operating liabilities for fiscal 2024 was $9.62M, a 8649.09% increase from fiscal 2023.
- CRISPR THERAPEUTICS AG increase (decrease) in other operating liabilities for fiscal 2023 was $110.00K.
- CRISPR THERAPEUTICS AG increase (decrease) in other operating liabilities for fiscal 2022 was -$1.52M.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $3.95M 10-Q · filed 2026-08-03 | $17.50M derived: sum of 3 quarters · filed 2026-08-03 | $18.30M derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | -$199.00K 10-Q · filed 2026-05-04 | $13.36M derived: sum of 2 quarters · filed 2026-05-04 | $14.16M derived: sum of 3 quarters · filed 2026-05-04 | $14.60M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | $13.55M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $14.36M derived: sum of 2 quarters · filed 2026-02-12 | $14.80M derived: sum of 3 quarters · filed 2026-08-03 | $4.26M 10-K · filed 2026-02-12 |
| 2025-09-30 | $802.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $1.25M derived: sum of 2 quarters · filed 2026-08-03 | -$9.30M 10-Q · filed 2025-11-10 | $689.00K derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | $443.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | -$10.10M 10-Q · filed 2026-08-03 | -$113.00K derived: sum of 3 quarters · filed 2026-08-03 | -$82.00K derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | -$10.54M 10-Q · filed 2026-05-04 | -$556.00K derived: sum of 2 quarters · filed 2026-05-04 | -$525.00K derived: sum of 3 quarters · filed 2026-05-04 | -$485.00K derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $9.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $10.02M derived: sum of 2 quarters · filed 2026-02-12 | $10.06M derived: sum of 3 quarters · filed 2026-02-12 | $9.62M 10-K · filed 2026-02-12 |
| 2024-09-30 | $31.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $71.00K derived: sum of 2 quarters · filed 2025-11-10 | -$361.00K 10-Q · filed 2025-11-10 | $344.00K derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-06-30 | $40.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | -$392.00K 10-Q · filed 2025-08-04 | $313.00K derived: sum of 3 quarters · filed 2026-02-12 | $203.00K derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-03-31 | -$432.00K 10-Q · filed 2025-05-06 | $273.00K derived: sum of 2 quarters · filed 2026-02-12 | $163.00K derived: sum of 3 quarters · filed 2026-02-12 | -$152.00K derived: sum of 4 quarters · filed 2026-02-12 |
| 2023-12-31 | $705.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $595.00K derived: sum of 2 quarters · filed 2026-02-12 | $280.00K derived: sum of 3 quarters · filed 2026-02-12 | $110.00K 10-K · filed 2026-02-12 |
| 2023-09-30 | -$110.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | -$425.00K derived: sum of 2 quarters · filed 2024-11-05 | -$595.00K 10-Q · filed 2024-11-05 | $59.00K derived: sum of 4 quarters · filed 2025-02-11 |
| 2023-06-30 | -$315.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | -$485.00K 10-Q · filed 2024-08-05 | $169.00K derived: sum of 3 quarters · filed 2025-02-11 | -$858.00K derived: sum of 4 quarters · filed 2025-02-11 |
| 2023-03-31 | -$170.00K 10-Q · filed 2024-05-08 | $484.00K derived: sum of 2 quarters · filed 2025-02-11 | -$543.00K derived: sum of 3 quarters · filed 2025-02-11 | -$1.54M derived: sum of 4 quarters · filed 2025-02-11 |
| 2022-12-31 | $654.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-11 | -$373.00K derived: sum of 2 quarters · filed 2025-02-11 | -$1.37M derived: sum of 3 quarters · filed 2025-02-11 | -$1.52M 10-K · filed 2025-02-11 |
| 2022-09-30 | -$1.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | -$2.02M derived: sum of 2 quarters · filed 2023-11-06 | -$2.17M 10-Q · filed 2023-11-06 | -$997.00K derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-06-30 | -$994.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | -$1.15M 10-Q · filed 2023-08-07 | $30.00K derived: sum of 3 quarters · filed 2024-02-21 | -$583.00K derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-03-31 | -$154.00K 10-Q · filed 2022-05-09 | $1.02M derived: sum of 2 quarters · filed 2024-02-21 | $411.00K derived: sum of 3 quarters · filed 2024-02-21 | -$1.69M derived: sum of 4 quarters · filed 2024-02-21 |
| 2021-12-31 | $1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $565.00K derived: sum of 2 quarters · filed 2024-02-21 | -$1.54M derived: sum of 3 quarters · filed 2024-02-21 | -$5.30M 10-K · filed 2024-02-21 |
| 2021-09-30 | -$613.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | -$2.72M derived: sum of 2 quarters · filed 2022-11-01 | -$6.48M 10-Q · filed 2022-11-01 | -$10.95M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-06-30 | -$2.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$5.87M 10-Q · filed 2022-08-08 | -$10.34M derived: sum of 3 quarters · filed 2023-02-21 | -$12.73M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-03-31 | -$3.77M 10-Q · filed 2022-05-09 | -$8.24M derived: sum of 2 quarters · filed 2023-02-21 | -$10.62M derived: sum of 3 quarters · filed 2023-02-21 | -$12.67M derived: sum of 4 quarters · filed 2023-02-21 |
| 2020-12-31 | -$4.47M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | -$6.86M derived: sum of 2 quarters · filed 2023-02-21 | -$8.91M derived: sum of 3 quarters · filed 2023-02-21 | -$10.51M 10-K · filed 2023-02-21 |
| 2020-09-30 | -$2.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | -$4.44M derived: sum of 2 quarters · filed 2021-11-03 | -$6.04M 10-Q · filed 2021-11-03 | $19.07M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-06-30 | -$2.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | -$3.65M 10-Q · filed 2021-07-29 | $21.46M derived: sum of 3 quarters · filed 2022-02-15 | $21.32M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-03-31 | -$1.60M 10-Q · filed 2021-04-27 | $23.51M derived: sum of 2 quarters · filed 2022-02-15 | $23.38M derived: sum of 3 quarters · filed 2022-02-15 | $23.58M derived: sum of 4 quarters · filed 2022-02-15 |
| 2019-12-31 | $25.11M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $24.98M derived: sum of 2 quarters · filed 2022-02-15 | $25.18M derived: sum of 3 quarters · filed 2022-02-15 | $24.98M 10-K · filed 2022-02-15 |
| 2019-09-30 | -$133.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-28 | $67.00K derived: sum of 2 quarters · filed 2020-10-28 | -$127.00K 10-Q · filed 2020-10-28 | $84.00K derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-06-30 | $200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-27 | $6.00K 10-Q · filed 2020-07-27 | $217.00K derived: sum of 3 quarters · filed 2021-02-16 | $167.00K derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-03-31 | -$194.00K 10-Q · filed 2020-04-28 | $17.00K derived: sum of 2 quarters · filed 2021-02-16 | -$33.00K derived: sum of 3 quarters · filed 2021-02-16 | $30.00K derived: sum of 4 quarters · filed 2021-02-16 |
| 2018-12-31 | $211.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | $161.00K derived: sum of 2 quarters · filed 2021-02-16 | $224.00K derived: sum of 3 quarters · filed 2021-02-16 | $249.00K 10-K · filed 2021-02-16 |
| 2018-09-30 | -$50.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-28 | $13.00K derived: sum of 2 quarters · filed 2019-10-28 | $38.00K 10-Q · filed 2019-10-28 | $277.00K derived: sum of 4 quarters · filed 2020-02-12 |
| 2018-06-30 | $63.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-29 | $88.00K 10-Q · filed 2019-07-29 | $327.00K derived: sum of 3 quarters · filed 2020-02-12 | $80.00K derived: sum of 4 quarters · filed 2020-02-12 |
| 2018-03-31 | $25.00K 10-Q · filed 2019-04-29 | $264.00K derived: sum of 2 quarters · filed 2020-02-12 | $17.00K derived: sum of 3 quarters · filed 2020-02-12 | $291.00K derived: sum of 4 quarters · filed 2020-02-12 |
| 2017-12-31 | $239.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-12 | -$8.00K derived: sum of 2 quarters · filed 2020-02-12 | $266.00K derived: sum of 3 quarters · filed 2020-02-12 | $270.00K 10-K · filed 2020-02-12 |
| 2017-09-30 | -$247.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $27.00K derived: sum of 2 quarters · filed 2018-11-07 | $31.00K 10-Q · filed 2018-11-07 | $3.00K derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-06-30 | $274.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $278.00K 10-Q · filed 2018-08-07 | $250.00K derived: sum of 3 quarters · filed 2019-02-25 | $210.00K derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-03-31 | $4.00K 10-Q · filed 2018-05-08 | -$24.00K derived: sum of 2 quarters · filed 2019-02-25 | -$64.00K derived: sum of 3 quarters · filed 2019-02-25 | -$48.00K derived: sum of 4 quarters · filed 2019-02-25 |
| 2016-12-31 | -$28.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | -$68.00K derived: sum of 2 quarters · filed 2019-02-25 | -$52.00K derived: sum of 3 quarters · filed 2019-02-25 | -$17.00K 10-K · filed 2019-02-25 |
| 2016-09-30 | -$40.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$24.00K derived: sum of 2 quarters · filed 2017-11-08 | $11.00K 10-Q · filed 2017-11-08 | -$24.00K derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-06-30 | $16.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $51.00K 10-Q · filed 2017-08-10 | $16.00K derived: sum of 3 quarters · filed 2018-03-08 | |
| 2016-03-31 | $35.00K 10-Q · filed 2017-05-11 | $0.00 derived: sum of 2 quarters · filed 2018-03-08 | ||
| 2015-12-31 | -$35.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $14.00K 10-K · filed 2018-03-08 | ||
| 2015-09-30 | $49.00K 10-Q · filed 2016-11-22 | |||
| 2014-12-31 | -$21.00K 10-K · filed 2017-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |